PFE Stock Price - Pfizer Inc - (PFE)
- Prev. Close: 33.26
- Open: 33.3
- Daily Range: 32.50 - 33.36
PFE NEWS FROM BIDNESS ETC
Pfizer Inc. Sells Off 4 Drugs To Alvogen: A Smart Decision?
Pfizer sells off four of its drugs to Alvogen, as the company looks to meet the regulatory requirements to complete its $16 billion acquisition of Hos...
Pfizer Inc. To Complete Hospira, Inc. Acquisition Next Month
Bidness Etc takes a look at the upcoming acquisition of Hospira by Pfizer, and its impact on the generic drug industry
Cancer Immunotherapy - Pfizer Inc., Bristol-Myers Squibb Co Research New Ap...
The newest cancer immunotherapy approach works by intensifying immune system response, rather than just triggering it
- Will Novartis AG (ADR) Buy Pfizer Inc. Biosimilar Remicade?
- Pfizer Inc. To Acquire Generic Version Of Teva Pharmaceutical Industries Lt...
- Pfizer Inc. (PFE) Surges On Q215 Earnings
- Earnings Whispers: Pfizer Inc. (PFE) & United Parcel Service, Inc. (UPS...
- Pfizer Inc. (PFE) Q2 Earnings: What To Expect?
- Here’s How Pfizer Inc., GlaxoSmithKline plc Vaccines Deal Works For Both ...
- Merck & Co., GlaxoSmithKline plc, & Others Expected To Be Neck-And-...
- GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche Ho...
- Pfizer Inc. (PFE) To Boost Production In China With $95 Million Plant
More News From Bidness
Insider Selling: Pfizer Inc. (PFE), Goldman Sachs Group... PUBLISHED: Jun 13, 2015 at 10:00 am ESTPfizer Inc. Wards Off Another Birth Defect Case Against... PUBLISHED: Jun 12, 2015 at 7:03 am ESTPfizer Inc. Still In Trouble Over Anti-depressant Drug ... PUBLISHED: Jun 9, 2015 at 6:38 am ESTInsider Selling: Pfizer Inc. (PFE), Anthem Inc (ANTM), ... PUBLISHED: Jun 3, 2015 at 8:28 am EST
Pfizer Inc. (PFE) Split Could Be Announced By 2015-2016: JPMorgan PUBLISHED: Jun 1, 2015 at 6:54 am EST
Pfizer Inc. Interested In Acquiring French Biotech Firm Cellectis SA (ADR) (CLLS): Sources PUBLISHED: Jun 1, 2015 at 6:54 am EST
Pfizer is rumored to be eyeing French cancer drug-maker Cellectis for an acquisitionREAD MORE
Pfizer Inc. Gets FDA Green Signal For The First Drug To Treat A Rare Lung Disease PUBLISHED: May 29, 2015 at 6:25 am EST
Pfizer’s Rapamune is the first drug approved by FDA to treat a very rare, progressive lung diseaseREAD MORE
Driven By Pfizer Inc. And Novartis AG (ADR), Global Breast Cancer Drug Sales Expected To Soar By 2020 PUBLISHED: May 23, 2015 at 9:06 am EST
Global sales of branded breast cancer drugs by Pfizer, Roche, Novartis, and many other drug-makers may soar past $25 billion in 2020, Bloomberg reportsREAD MORE
Pfizer Inc. Mega-Merger Talk: The Speculated Targets PUBLISHED: May 22, 2015 at 8:04 am EST
Bidness Etc looks at the possible takeover options for Pfizer, as cited by analystsREAD MORE
Pfizer Inc.-GlaxoSmithKline Merger Talk: Deutsche Bank Speculates “PfizerKline” PUBLISHED: May 21, 2015 at 8:02 am EST
Bidness Etc takes a look at Deutsche Bank’s views on a possible Pfizer-Glaxo mega-mergerREAD MORE
Pfizer Inc. To See Boosting Revenues On New Drugs Growth Through 2020 PUBLISHED: May 20, 2015 at 11:29 am EST
The company’s stock, expected to soar on significant boost in revenues fuelled by new drugs growth in the coming years, is bound to reap high returns for the investors in the long run; Pfizer’s stock thus presents a perfect buying opportunity rig...READ MORE